The Department of Science and Technology (DOST) has explained why the country’s eight month-long clinical trial seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in...
The Department of Science and Technology (DOST) has logged more than 40 participants in the country’s “Mix and Match” (MnM) study. (MANILA BULLETIN FILE) The 18 month-long study seeks to evaluate the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and...
The country’s P240-million “Mix and Match” (MnM) study seeking to evaluate the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and vaccine platforms in Filipino adults is expected to be rolled out in in Muntinlupa City next week, the Department of Science...
The Department of Science and Technology (DOST) bared Wednesday, Nov. 17, innovation breakthroughs that would help the country achieve its “kaayusan” and “kinabukasan” development goals. (DOST-NRDC Facebook page) Unveiled during the second leg of the 6th National Research and Development...
The Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) is supporting a 14 month-long project seeking to validate a rapid, simple and efficient isothermal coronavirus disease (COVID-19) testing technology. (Photo by Mufid Majnun on Unsplash) This...
The public can expect the launch of newly developed diagnostic test kits for other communicable diseases such as leptospirosis, tuberculosis, and human immunodeficiency virus (HIV) by the end of 2022 to 2023. (Photo by JC Gellidon on Unsplash) The Department of Science and Technology (DOST) said...
The Department of Science and Technology (DOST) said Friday, Nov. 12, that the recruitment of 3,000 participants for the country’s “Mix and Match” (MnM) study has yet to start. (MANILA BULLETIN FILE) DOST Undersecretary for Research and Development Dr. Rowena Cristina L. Guevara said they...
The Department of Science and Technology (DOST) said the “latest protocol" for the country’s eight month-long clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients...
The Department of Science and Technology (DOST) said more than 1,900 participants of the World Health Organization’s (WHO) Solidarity Trial for Vaccines in the country have already received their first dose of jabs against the coronavirus disease (COVID-19). (MANILA BULLETIN FILE PHOTO) DOST...
To make the Philippines equipped to counter bigger challenges in the future, more investments should be poured into the country’s human capital and that the annual allocation for research and development (R&D) should be increased. Department of Science and Technology (DOST) Undersecretary for...
The Department of Science and Technology (DOST) expressed hope Wednesday, Nov. 10, that the Food and Drug Administration (FDA) will soon give its go signal for the conduct of the “Mix and Match” (MnM) trial which seeks to determine the safety and immunogenicity of mixing different coronavirus...
Six more sites have been identified for the country’s yearlong real-world study on the effectiveness of coronavirus disease (COVID-19) vaccines, the Department of Science and Technology (DOST) said on Monday, Oct. 25. (Joe Raedle/Getty Images/AFP / MANILA BULLETIN) DOST Undersecretary for...
